The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Antimicrobial Efficacy of Riboflavin/UVA Combination (365 nm) In Vitro for Bacterial and Fungal Isolates: A Potential New Treatment for Infectious Keratitis
Abstract
PURPOSE: To demonstrate the antimicrobial properties of riboflavin/UVA (365 nm) against common pathogens. METHODS: One group of bacteria (Pseudomonas aeruginosa [PA], Staphylococcus aureus [SA], and Staphylococcus epidermidis [SE]) was tested by using Kirby-Bauer discs with (1) empty disc (Control - C); (2) riboflavin 0.1% (B2); (3) riboflavin 0.1% previously activated by UVA (B2'); (4) UVA alone (UVA); (5) group 2+additional UVA exposure (UVA+B2); and (6) group 3+additional UVA exposure (UVA+B2'). In addition, another group of microbes was tested with the same approach: methicillin-resistant S. aureus (MRSA), multidrug-resistant P. aeruginosa (MDRPA), drug-resistant Streptococcus pneumoniae (DRSP), and Candida albicans (CA). The mean growth inhibition zone (GIZ) in square millimeters was measured around the discs. The mean standard deviation (MSD) was calculated to be 3.65 when alpha = 0.01. A mean deviation (MD) > MSD indicates a significant difference. RESULTS: In the first group, the GIZ was significantly greater after UVA (MD = 14.30), UVA+B2 (MD = 39.61), and UVA+B2' (MD = 40.45) when compared with C, B2, and B2'. UVA alone was less effective than UVA+B2 (MD = 25.31) and UVA+B2' (MD = 26.15). The second group demonstrated increased GIZ in UVA (MD = 6.98), UVA+B2 (MD = 17.80), and UVA+B2' (MD = 21.15) when compared with C, B2, and B2'. UVA alone was less effective against the second group of bacteria than was UVA+B2 (MD = 10.82) and UVA+B2' (MD = 14.17). CA did not show any GIZ after treatment. CONCLUSIONS: Riboflavin/UVA was effective against SA, SE, PA, MRSA, MDRPA, and DRSP, but was ineffective on CA and has the potential for use in treatment of microbial keratitis in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Cited by 16,875
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · Pediatrics · doi:10.1542/peds.65.1.187 · Cited by 14,751
Riboflavin/ultraviolet-a–induced collagen crosslinking for the treatment of keratoconus
Wollensak, G., Spoerl, E., & Seiler, T. (2003) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(02)02220-1 · Cited by 2,968
The crisis in antibiotic resistance
Neu, H. C. (1992) · Science · doi:10.1126/science.257.5073.1064 · Cited by 2,834 · cited 1×
“Microbes cleverly develop resistance to antibiotics as a result of chromosomal mutation, inductive expression of a latent chromosomal genes, or exchange of genetic material via transformation, bacteriophage transduction, or plasmid conjugation.(1,4) Use of the fluoroquinolones in the management of external infections…”
BackgroundClinical Microbiology Procedures Handbook
(2016) · ASM Press eBooks · doi:10.1128/9781555818814 · Cited by 2,240
Disinfection, Sterilization, and Preservation
Block, S. S. (1977) · Soil Science · doi:10.1097/00010694-197712000-00013 · Cited by 1,963
Bass, M. A. (1994) · Cited by 1,082
Wollensak, G., Spoerl, E., & Seiler, T. (2003) · Journal of Cataract and Refractive Surgery · doi:10.1016/s0886-3350(03)00407-3 · Cited by 1,024
Safety of UVA-Riboflavin Cross-Linking of the Cornea
Spoerl, E., Mrochen, M., Sliney, D., Trokel, S., & Seiler, T. (2007) · Cornea · doi:10.1097/ico.0b013e3180334f78 · Cited by 809
Increased resistance of crosslinked cornea against enzymatic digestion
Spoerl, E., Wollensak, G., & Seiler, T. G. (2004) · Current Eye Research · doi:10.1080/02713680490513182 · Cited by 658
Cited by
Update on the Management of Infectious Keratitis
Austin, A., Lietman, T., & Rose-Nussbaumer, J. (2017) · Ophthalmology · doi:10.1016/j.ophtha.2017.05.012 · Cited by 613
Metadata
- Authors
- Martins, S. A. R., Combs, J. C., Noguera, G., Camacho, W., Wittmann, P., Walther, R., Cano, M., Dick, J., & Behrens, A.
- Venue
- Investigative Opthalmology & Visual Science
- Published
- 2008-08-01
- Volume
- 49
- Issue
- 8
- Pages
- 3402
- ISSN
- 0146-0404 (ISSN-L)
- 1552-5783
- OpenAlex
- W2074618935
- Cited by
- 270
- References
- 29
- FWCI
- 7.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.